In the present study, we report that the inhibition of miR‐27b improved neurogenesis in DG and SVZ via activating AMPK, and enhanced post‐stroke recovery in a mouse MCAo model, which may become a potential therapeutic option for ischemic stroke. Here, PRKAA2 is linked to ischemic stroke.